|
|
Article: Medtronic Responds to "Inequitable Conduct" Decision by U.S. District Court in Stent Litigation.
- Article from:
- Business Wire
- Article date:
- April 24, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Medtronic Will Appeal Ruling to Federal Circuit Court of Appeals
MINNEAPOLIS -- Today, the U.S. District Court for the District of Delaware ruled that Advanced Cardiovascular Systems, Inc., a subsidiary of Guidant Corporation which is now owned by Abbott Laboratories (NYSE:ABT), did not commit "inequitable conduct" in obtaining the Lau stent patents. The District Court's ruling completes the liability phase of the patent infringement proceeding brought by Guidant against Medtronic Vascular, while the damages phase remains to be conducted. Medtronic (NYSE:MDT) will appeal these findings of liability to the Federal Circuit Court of Appeals.
Today's ...